Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Cannabis in Palliative Pancreatic Cancer
NCT03245658Phase 2Withdrawn
- Start
- Oct 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, dronabinol in cancer cachexia. Planned start Oct 2017; status: withdrawn.
02
Drugs
cannabidioldronabinol
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT03245658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245658.